{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T02:14:11Z","timestamp":1794708851444,"version":"4.9.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.atherosclerosis.2026.120665","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T16:36:05Z","timestamp":1770914165000},"page":"120665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Non\u2013HDL cholesterol and remnant cholesterol are better indicators of atherosclerotic cardiovascular disease risk than LDL cholesterol in patients with chronic kidney disease"],"prefix":"10.1016","volume":"415","author":[{"given":"Man","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Jie","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu-Liu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Jie","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Hao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shou-Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0176-5204","authenticated-orcid":false,"given":"Hai-Yan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9887","key":"10.1016\/j.atherosclerosis.2026.120665_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","article-title":"Evolving importance of kidney disease: from subspecialty to global health burden","volume":"382","author":"Eckardt","year":"2013","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120665_bib2","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.cmet.2015.09.002","article-title":"Activation of cardiac fibroblast growth factor receptor 4 causes left ventricular hypertrophy","volume":"22","author":"Grabner","year":"2015","journal-title":"Cell Metab"},{"issue":"13","key":"10.1016\/j.atherosclerosis.2026.120665_bib3","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1001\/jama.2019.14745","article-title":"Chronic kidney disease diagnosis and management: a review","volume":"322","author":"Chen","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120665_bib4","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","article-title":"A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases","volume":"96","author":"Jager","year":"2019","journal-title":"Kidney Int"},{"issue":"10075","key":"10.1016\/j.atherosclerosis.2026.120665_bib5","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120665_bib6","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1038\/s41467-020-18519-0","article-title":"Irf1-mediated downregulation of pgc1\u03b1 contributes to cardiorenal syndrome type 4","volume":"11","author":"Huang","year":"2020","journal-title":"Nat Commun"},{"issue":"9844","key":"10.1016\/j.atherosclerosis.2026.120665_bib7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2026.120665_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/nu14153243","article-title":"Trajectories of lipid profile and risk of carotid atherosclerosis progression: a longitudinal cohort study","volume":"14","author":"Yu","year":"2022","journal-title":"Nutrients"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.120665_bib9","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2021.01.027","article-title":"Apolipoprotein b and non-hdl cholesterol better reflect residual risk than ldl cholesterol in statin-treated patients","volume":"77","author":"Johannesen","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"32","key":"10.1016\/j.atherosclerosis.2026.120665_bib10","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the european atherosclerosis society consensus panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120665_bib11","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","article-title":"A century of cholesterol and coronaries: from plaques to genes to statins","volume":"161","author":"Goldstein","year":"2015","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120665_bib12","doi-asserted-by":"crossref","first-page":"F262","DOI":"10.1152\/ajprenal.00099.2005","article-title":"Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences","volume":"290","author":"Vaziri","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120665_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.kint.2016.02.026","article-title":"Disorders of lipid metabolism in nephrotic syndrome: mechanisms and consequences","volume":"90","author":"Vaziri","year":"2016","journal-title":"Kidney Int"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2026.120665_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17238763","article-title":"Risk factors for chronic kidney disease in older adults with hyperlipidemia and\/or cardiovascular diseases in taipei city, Taiwan: a community-based cross-sectional analysis","volume":"17","author":"Chang","year":"2020","journal-title":"Int J Environ Res Publ Health"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120665_bib15","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 esc\/eas guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the task force for the management of dyslipidaemias of the european society of cardiology (esc) and european atherosclerosis society (eas)","volume":"41","author":"Mach","year":"2019","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120665_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1053\/j.ajkd.2018.11.010","article-title":"Lipids, apolipoproteins, and risk of atherosclerotic cardiovascular disease in persons with ckd","volume":"73","author":"Bajaj","year":"2019","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120665_bib17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2215\/CJN.07320619","article-title":"Apolipoprotein b, triglyceride-rich lipoproteins, and risk of cardiovascular events in persons with ckd","volume":"15","author":"Lamprea-Montealegre","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2026.120665_bib18","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/eurheartj\/ehac783","article-title":"What is 'remnant cholesterol'","volume":"44","author":"St\u00fcrzebecher","year":"2023","journal-title":"Eur Heart J"},{"issue":"42","key":"10.1016\/j.atherosclerosis.2026.120665_bib19","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1093\/eurheartj\/ehab432","article-title":"Remnant cholesterol predicts cardiovascular disease beyond ldl and apob: a primary prevention study","volume":"42","author":"Quispe","year":"2021","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.atherosclerosis.2026.120665_bib20","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","article-title":"Remnant cholesterol, not ldl cholesterol, is associated with incident cardiovascular disease","volume":"76","author":"Casta\u00f1er","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120665_bib21","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1373\/clinchem.2017.279463","article-title":"Remnant cholesterol and myocardial infarction in normal weight, overweight, and obese individuals from the copenhagen general population study","volume":"64","author":"Varbo","year":"2018","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120665_bib22","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/ana.25432","article-title":"Remnant cholesterol and risk of ischemic stroke in 112,512 individuals from the general population","volume":"85","author":"Varbo","year":"2019","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120665_bib23","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12933-022-01541-5","article-title":"Triglyceride-glucose index variability and incident cardiovascular disease: a prospective cohort study","volume":"21","author":"Li","year":"2022","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120665_bib24","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1161\/CIRCRESAHA.120.317950","article-title":"Arterial stiffness preceding diabetes: a longitudinal study","volume":"127","author":"Zheng","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2026.120665_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.118585","article-title":"Association between different stages of cardiovascular-kidney-metabolic syndrome and the risk of all-cause mortality","volume":"397","author":"Li","year":"2024","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2026.120665_bib26","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/eurjpc\/zwad398","article-title":"Life's essential 8 and heart failure among patients with chronic kidney disease: the kailuan cohort study","volume":"31","author":"Huo","year":"2024","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120665_bib27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12933-024-02249-4","article-title":"Association of the triglyceride-glucose index with early-onset atherosclerotic cardiovascular disease events and all-cause mortality: a prospective cohort study","volume":"23","author":"Hou","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120665_bib28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1186\/s12933-024-02290-3","article-title":"Association of triglyceride-glucose index and its related parameters with atherosclerotic cardiovascular disease: evidence from a 15-year follow-up of kailuan cohort","volume":"23","author":"Xia","year":"2024","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120665_bib29","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.CIR.90.1.583","article-title":"Myocardial infarction and coronary deaths in the world health organization monica project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents","volume":"90","author":"Tunstall-Pedoe","year":"1994","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120665_bib30","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1161\/01.STR.20.10.1407","article-title":"Recommendations on stroke prevention, diagnosis, and therapy. Report of the who task force on stroke and other cerebrovascular disorders","volume":"20","year":"1989","journal-title":"Stroke"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120665_bib31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.2215\/CJN.09270816","article-title":"Sleep and ckd in chinese adults: a cross-sectional study","volume":"12","author":"Li","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.atherosclerosis.2026.120665_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1251344","article-title":"Cumulative exposure to remnant cholesterol and the risk of fragility fractures: a longitudinal cohort study","volume":"14","author":"Hou","year":"2023","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120665_bib33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s12933-023-01984-4","article-title":"Cumulative exposure to high remnant-cholesterol concentrations increases the risk of cardiovascular disease in patients with hypertension: a prospective cohort study","volume":"22","author":"Wu","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120665_bib34","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1002\/ijc.31149","article-title":"Association of total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol with atherosclerotic cardiovascular disease and cancer in a chinese male population","volume":"142","author":"Guan","year":"2018","journal-title":"Int J Cancer"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120665_bib35","first-page":"599","article-title":"Relative performance of two equations for estimation of glomerular filtration rate in a chinese population having chronic kidney disease","volume":"125","author":"Li","year":"2012","journal-title":"Chin Med J (Engl)"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.120665_bib36","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2337\/dc20-2375","article-title":"Associations of type 2 diabetes onset age with cardiovascular disease and mortality: the kailuan study","volume":"44","author":"Zhao","year":"2021","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2026.120665_bib37","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.25876","article-title":"Analysis of changes in weight, waist circumference, or both, and all-cause mortality in chinese adults","volume":"5","author":"Yuan","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120665_bib38","first-page":"83","article-title":"Predictive values of body mass index and waist circumference for risk factors of certain related diseases in chinese adults--study on optimal cut-off points of body mass index and waist circumference in chinese adults","volume":"15","author":"Zhou","year":"2002","journal-title":"Biomed Environ Sci"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.120665_bib39","first-page":"330","volume":"52","year":"2024","journal-title":"Zhonghua Xinxueguanbing Zazhi"},{"key":"10.1016\/j.atherosclerosis.2026.120665_bib40","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2016.08.018","volume":"253","author":"Catapano","year":"2016","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120665_bib41","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.123.064296","article-title":"Childhood non-hdl cholesterol and ldl cholesterol and adult atherosclerotic cardiovascular events","volume":"149","author":"Wu","year":"2024","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2026.120665_bib42","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1161\/CIRCRESAHA.119.315019","article-title":"Apob","volume":"124","author":"Sniderman","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2026.120665_bib43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.amjcard.2022.01.034","article-title":"Serum low-density lipoprotein cholesterol and cardiovascular disease risk across chronic kidney disease stages (data from 1.9 million United States veterans)","volume":"170","author":"Hashemi","year":"2022","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120665_bib44","article-title":"Remnant cholesterol and atherosclerotic cardiovascular disease: metabolism, mechanism, evidence, and treatment","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.120665_bib45","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.113.005873","article-title":"Discordance of low-density lipoprotein (ldl) cholesterol with alternative ldl-related measures and future coronary events","volume":"129","author":"Mora","year":"2014","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120665_bib46","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.959247","article-title":"A meta-analysis of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein b as markers of cardiovascular risk","volume":"4","author":"Sniderman","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.120665_bib47","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/ana.26425","article-title":"Apob and non-hdl cholesterol versus ldl cholesterol for ischemic stroke risk","volume":"92","author":"Johannesen","year":"2022","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120665_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jacc.2009.07.057","volume":"55","author":"Arsenault","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.120665_bib49","article-title":"2023 chinese guideline for lipid management","volume":"14","author":"Li","year":"2023","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.120665_bib50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.12997\/jla.2023.12.2.164","article-title":"Higher non-high-density lipoprotein cholesterol was higher associated with cardiovascular disease comparing higher ldl-c in nine years follow up: cohort study","volume":"12","author":"Hong","year":"2023","journal-title":"J Lipid Atheroscler"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120665_bib51","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024637","article-title":"Age-related associations of low-density lipoprotein cholesterol and atherosclerotic cardiovascular disease: a nationwide population-based cohort study","volume":"11","author":"Jung","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"10.1016\/j.atherosclerosis.2026.120665_bib52","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1093\/eurjpc\/zwad297","article-title":"Cumulative remnant cholesterol predicts cardiovascular outcomes in elderly patients with atherosclerotic cardiovascular disease","volume":"30","author":"Xiao","year":"2023","journal-title":"Eur J Prev Cardiol"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120665_bib53","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024248","article-title":"Low-density lipoprotein cholesterol attributable cardiovascular disease risk is sex specific","volume":"11","author":"Cupido","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2026.120665_bib54","doi-asserted-by":"crossref","first-page":"134","DOI":"10.12688\/f1000research.9845.1","article-title":"Apolipoprotein b-containing lipoproteins and atherosclerotic cardiovascular disease","volume":"6","author":"Shapiro","year":"2017","journal-title":"F1000Res"},{"issue":"16","key":"10.1016\/j.atherosclerosis.2026.120665_bib55","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1161\/01.CIR.0000035280.64322.31","article-title":"New perspectives on atherogenesis: role of abnormal triglyceride-rich lipoprotein metabolism","volume":"106","author":"Ginsberg","year":"2002","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.120665_bib56","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1194\/jlr.P900003-JLR200","article-title":"Chronic kidney disease delays vldl-apob-100 particle catabolism: potential role of apolipoprotein c-iii","volume":"50","author":"Chan","year":"2009","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.120665_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-69794-2","article-title":"There is a u shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3-5","volume":"10","author":"Chiu","year":"2020","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.120665_bib58","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.5551\/jat.34660","article-title":"Efficacy of statin therapy in inducing coronary plaque regression in patients with low baseline cholesterol levels","volume":"23","author":"Wakabayashi","year":"2016","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.atherosclerosis.2026.120665_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ctim.2017.05.006","article-title":"Curcuminoids modify lipid profile in type 2 diabetes mellitus: a randomized controlled trial","volume":"33","author":"Panahi","year":"2017","journal-title":"Complement Ther Med"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026000316?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026000316?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:35:34Z","timestamp":1779251734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026000316"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":59,"alternative-id":["S0021915026000316"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120665","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non\u2013HDL cholesterol and remnant cholesterol are better indicators of atherosclerotic cardiovascular disease risk than LDL cholesterol in patients with chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.120665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120665"}}